Keywords: tercica, submits, nda, increlex, short, stature, usa

Tercica submits NDA for Increlex, for short stature, in USA

Article | 07 March 2005

Print This

USA-based Tercica says that it has submitted a New Drug Application to the US Food and Drug Administration to market ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in